Paris-Saclay University campus

Health Sciences

Master 2 – Biotechnologie Pharmaceutique et thérapies innovantes at Paris-Saclay University

Paris-Saclay University, France

Programme overview

The M2 Pharmaceutical Biotechnology and Innovative Therapies, in apprenticeship or initial training, focuses on biotechnology innovations in the production and control of biomedicines and innovative (gene and cell) therapies.

Department: Mention Sciences du médicament et des produits de santé  |  Duration: 1 year (M2)  |  Study mode: full-time; taught in French  |  Intake: Indicative start date 07/09/2026  |  Location: Gif-sur-Yvette, Île-de-France, France

What you will study

Describing the steps for obtaining therapeutic proteins and monoclonal antibodies.

Career pathways

Study officer, project manager; doctorate.

Official programme page

Application information

Entry requirements

Students who validated the corresponding SMPS M1 sub-track or the first year of a compatible master (chemistry-biology interface). Application: platform Inception; from 10/03/2026 to 11/04/2026. 25 places.

EUR 255 a year (2026/2027). National registration fee for the master cursus 2026-2027 (full rate, first cursus). Non-EU students under differentiated fees receive a partial exemption bringing them to the national amount. CVEC and other ancillary fees excluded. Source

Intake: Indicative start date 07/09/2026

Duration: 1 year (M2)

Explore more study programmes

View all study programmes →

Ready to start your study abroad journey?

Book a free consultation with our expert counsellors and take the first step towards your dream university.

Copyrights © 2026 StudyMapped. All rights reserved.